Clinical Trials Browser

OTHER × Lymphoma, Large-Cell, Anaplastic × brigatinib × Clear all

NCT04925609 2025-12-05

Briga-PED

Phase 1/2 Recruiting

LymphoidPlasma cell

Granuloma, Plasma Cell, Lymphoma, Large-Cell, Anaplastic

NCT03719898 2021-01-05

Brigatinib in Relapsed or Refractory ALK-Positive Anaplastic Large Cell Lymphoma

Phase 2 Withdrawn

Lymphoma, Large-Cell, Anaplastic